opentargets-database

To identify therapeutic targets for a specific disease, query the Open Targets Platform GraphQL API to retrieve target-disease associations and genetic evidence. This facilitates therapeutic target identification and prioritization in drug discovery.

Yes, you can assess drug safety and druggability for target validation by querying integrated biological and clinical data. The API retrieves safety profiles and tractability information to validate potential drug targets.

Find existing drugs for drug repurposing by querying the Open Targets Platform for drug information and disease associations. This retrieves known drugs that could potentially be used for new indications.

Yes, querying the GraphQL API requires the requests library. This dependency enables programmatic access to retrieve and analyze integrated genetic evidence and pharmacology data.

The best way to search for genetic evidence associated with Alzheimer's disease is using the Open Targets Platform API. Search for associated genes, then review their genetic evidence, tractability, and safety profiles.

Limitations of retrieving disease association data through the GraphQL API include dependency on the Open Targets Platform's integrated data scope. Target identification and validation rely on the available genetic evidence, drug information, and safety profiles.